The inventions described herein relate to devices and associated methods for the treatment of chronic total occlusions. More particularly, the inventions described herein relate to devices and methods for crossing chronic total occlusions and establishing a pathway blood flow past the chronic total occlusions.
Due to age, high cholesterol and other contributing factors, a large percentage of the population has arterial atherosclerosis that totally occludes portions of the patient's vasculature and presents significant risks to patient health. For example, in the case of a total occlusion of a coronary artery, the result may be painful angina, loss of cardiac tissue or patient death. In another example, complete occlusion of the femoral and/or popliteal arteries in the leg may result in limb threatening ischemia and limb amputation.
Commonly known endovascular devices and techniques are either inefficient (time consuming procedure), have a high risk of perforating a vessel (poor safety) or fail to cross the occlusion (poor efficacy). Physicians currently have difficulty visualizing the native vessel lumen, cannot accurately direct endovascular devices toward the visualized lumen, or fail to advance devices through the lesion. Bypass surgery is often the preferred treatment for patients with chronic total occlusions, but less invasive techniques would be preferred.
Devices, systems and methods for treating diseases and disorders effecting the cardiovascular system of the human body are disclosed. An exemplary blood vessel in accordance with this disclosure comprises a shaft, tip member fixed to the shaft, and a probe extending beyond a distal surface of the tip member. In some useful embodiments, the tip member is relatively atraumatic and the probe is shaped so as to be more likely to produce trauma than the tip member.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
As used herein, the terms total occlusion and complete occlusion are intended to refer to the same or similar degree of occlusion with some possible variation in the age of the occlusion. Generally, a total occlusion refers to a vascular lumen that is ninety percent or more functionally occluded in cross-sectional area, rendering it with little to no blood flow therethrough and making it difficult or impossible to pass a conventional guide wire therethrough. Also generally, the older the total occlusion the more organized the occlusive material will be and the more fibrous and calcified it will become. According to one accepted clinical definition, a total occlusion is considered chronic if it is greater than two weeks old from symptom onset.
With reference to
In the embodiment of
Orienting element 120 comprises a first portion 106 and a second portion 108. First portion 106 of orienting element 120 extends in a first direction away from distal shaft 102. Second portion 108 of orienting element 120 extends away from distal shaft 102 in a second direction that is generally opposite the first direction.
Distal shaft 102 defines a first aperture 130 and a second aperture 132. First aperture 130 extends in a third direction through distal shaft 102. Second aperture 132 extends through distal shaft 102 in a forth direction that is generally opposite the third direction. First aperture 130 and second aperture 132 are generally oriented at a right angle to a tangent plane TP. In
When inflatable member 126 is inflated, the number of directions that first aperture 130 and second aperture 132 may be facing is reduced. This may be conceptualized in terms of degrees of freedom. When inflatable member 126 of orienting element 120 is inflated, the number of directions that an aperture may be facing is reduced from 360 degrees of freedom to two degrees of freedom, 180 degrees apart.
When inflatable member 126 of orienting element 120 is inflated between adventitia 24 and intima 26 of artery 20 orienting device 100 will orient itself within artery 20 so that either first aperture 130 or second aperture 132 opens toward a true lumen 30 of artery 20. In the embodiment of
In some useful methods in accordance with the present disclosure, crossing device 70 may be rotated about it's longitudinal axis and moved in a direction parallel to it's longitudinal axis simultaneously. When this is the case, rotation of crossing device 70 may reduce resistance to the axial advancement of crossing device 70. These methods take advantage of the fact that the kinetic coefficient of friction is usually less than the static coefficient of friction for a given frictional interface. Rotating crossing device 70 assures that the coefficient of friction at the interface between the crossing device and the surround tissue will be a kinetic coefficient of friction and not a static coefficient of friction.
Rotation of crossing device 70 can be achieved by rolling handle assembly 76 between the thumb and forefinger of one hand. Two hands may also be used to rotate handle assembly 76 as shown in
In some useful methods in accordance with the present disclosure, crossing device 70 is rotated at a rotational speed of between about 2 revolutions per minute and about 200 revolutions per minute. In some particularly useful methods in accordance with the present disclosure, crossing device 70 is rotated at a rotational speed of between about 50 revolutions per minute and about 150 revolutions per minute.
Crossing device 70 may be rotated by hand as depicted in
It is to be appreciated that other methods of crossing an occlusion are within the spirit and scope of this disclosure. For example, the crossing device 70 may pass through occlusion 36 while remaining disposed inside true lumen 30. In
In the embodiment of
The position of guidewire 60 shown in
With guidewire 60 in the position shown in
In the embodiment of
It the embodiment of
A first intermediate segment 262 of shaft 240 extends between first tapered segment 252 and a second tapered segment 254. A second intermediate segment 264 of shaft 240 extends between second tapered segment 254 and a third tapered segment 256. A distal segment 260 of shaft 240 extends between third tapered segment 256 and tip member 242. With reference to
A number of exemplary dimensions associated with probe 346 are illustrated in
In some useful embodiments, diameter DA of probe 346 is between about 0.0020 inches and about 0.0055 inches. In some useful embodiments, diameter DB of tip member 342 is between about 0.008 inches and about 0.035 inches. In some useful embodiments, length L of probe 346 is between about 0.003 inches and about 0.032 inches. In
Various processes may be used to fabricate a tip member having a shape similar to tip member 442 shown in
In the embodiment of
In the embodiment of
In
From the foregoing, it will be apparent to those skilled in the art that the present invention provides, in exemplary non-limiting embodiments, devices and methods for the treatment of chronic total occlusions. Further, those skilled in the art will recognize that the present invention may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. Accordingly, departures in form and detail may be made without departing from the scope and spirit of the present invention as described in the appended claims.
This application is a continuation of U.S. patent application Ser. No. 12/461,261, filed on Aug. 5, 2009, which claims the benefit of U.S. Provisional Application No. 61/104,868, filed on Oct. 13, 2008. U.S. patent application Ser. No. 12/461,261 is a continuation-in-part of application U.S. patent application Ser. No. 12/320,792, filed on Feb. 4, 2009, now U.S. Pat. No. 8,202,246, which claims the benefit of U.S. Provisional Application No. 61/063,756, filed on Feb. 5, 2008. The contents of the above-noted applications are expressly incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3749086 | Kline | Jul 1973 | A |
4020829 | Willson et al. | May 1977 | A |
4080706 | Heilman et al. | Mar 1978 | A |
4233983 | Rocco | Nov 1980 | A |
4534363 | Gold et al. | Aug 1985 | A |
4545390 | Leary | Oct 1985 | A |
4569347 | Frisbie | Feb 1986 | A |
4581017 | Sahota | Apr 1986 | A |
4619274 | Morrison | Oct 1986 | A |
4621636 | Fogarty | Nov 1986 | A |
4676249 | Arenas et al. | Jun 1987 | A |
4721117 | Mar et al. | Jan 1988 | A |
4747821 | Kensey et al. | May 1988 | A |
4748986 | Morrison et al. | Jun 1988 | A |
4762130 | Fogarty et al. | Aug 1988 | A |
4763647 | Gambale | Aug 1988 | A |
4774949 | Fogarty et al. | Oct 1988 | A |
4819634 | Shiber et al. | Apr 1989 | A |
4832047 | Sepetka et al. | May 1989 | A |
4841976 | Packard et al. | Jun 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4925445 | Sakamoto et al. | May 1990 | A |
4932419 | De Toledo et al. | Jun 1990 | A |
4976689 | Buchbinder et al. | Dec 1990 | A |
4979939 | Shiber et al. | Dec 1990 | A |
4984581 | Stice | Jan 1991 | A |
4990134 | Auth | Feb 1991 | A |
4991602 | Amplatz et al. | Feb 1991 | A |
5052404 | Hodgson et al. | Oct 1991 | A |
5067489 | Lind | Nov 1991 | A |
5069226 | Yamauchi et al. | Dec 1991 | A |
5071406 | Jang et al. | Dec 1991 | A |
5118907 | Stout | Jun 1992 | A |
5120308 | Hess et al. | Jun 1992 | A |
5127917 | Niederhauser et al. | Jul 1992 | A |
5129890 | Bates et al. | Jul 1992 | A |
5143122 | Adkins et al. | Sep 1992 | A |
5147317 | Shank et al. | Sep 1992 | A |
5154705 | Fleischhacker et al. | Oct 1992 | A |
5171383 | Sagae et al. | Dec 1992 | A |
5174302 | Palmer et al. | Dec 1992 | A |
5193546 | Shaknovich | Mar 1993 | A |
5201753 | Lampropoulos et al. | Apr 1993 | A |
5213111 | Cook et al. | May 1993 | A |
5228453 | Sepetka | Jul 1993 | A |
5230348 | Ishibe et al. | Jul 1993 | A |
5238004 | Sahatjian et al. | Aug 1993 | A |
5242759 | Hall | Sep 1993 | A |
5243996 | Hall | Sep 1993 | A |
5259393 | Corso et al. | Nov 1993 | A |
5263493 | Avitall | Nov 1993 | A |
5275610 | Eberbach et al. | Jan 1994 | A |
5282478 | Fleischhaker, Jr. et al. | Feb 1994 | A |
5303714 | Abele et al. | Apr 1994 | A |
5324263 | Kraus et al. | Jun 1994 | A |
5333620 | Moutafis et al. | Aug 1994 | A |
5354257 | Roubin et al. | Oct 1994 | A |
5354623 | Hall et al. | Oct 1994 | A |
5356418 | Shturman | Oct 1994 | A |
5363847 | Viera | Nov 1994 | A |
5365942 | Shank et al. | Nov 1994 | A |
5368048 | Stoy et al. | Nov 1994 | A |
5368049 | Raman et al. | Nov 1994 | A |
5372144 | Mortier et al. | Dec 1994 | A |
5372587 | Hammerslag et al. | Dec 1994 | A |
5373856 | Grenouillet | Dec 1994 | A |
5379779 | Rowland et al. | Jan 1995 | A |
5383856 | Bersin et al. | Jan 1995 | A |
5385152 | Abele et al. | Jan 1995 | A |
5409453 | Lundquist et al. | Apr 1995 | A |
5415178 | Hsi et al. | May 1995 | A |
5415637 | Khosravi et al. | May 1995 | A |
5421349 | Rodriguez et al. | Jun 1995 | A |
5443907 | Slaikeu et al. | Aug 1995 | A |
5458585 | Salmon et al. | Oct 1995 | A |
5464395 | Faxon et al. | Nov 1995 | A |
5465733 | Hinohara et al. | Nov 1995 | A |
5477864 | Davidson et al. | Dec 1995 | A |
5488959 | Ales | Feb 1996 | A |
5498250 | Prather | Mar 1996 | A |
5501667 | Verduin | Mar 1996 | A |
5505702 | Arney et al. | Apr 1996 | A |
5531781 | Alferness et al. | Jul 1996 | A |
5534007 | St. Germain et al. | Jul 1996 | A |
5542434 | Imran et al. | Aug 1996 | A |
5555883 | Avitall | Sep 1996 | A |
5571122 | Kelly et al. | Nov 1996 | A |
5571169 | Plaia et al. | Nov 1996 | A |
5603720 | Kieturakis et al. | Feb 1997 | A |
5622184 | Ashby et al. | Apr 1997 | A |
5636641 | Fariabi et al. | Jun 1997 | A |
5637089 | Abrams et al. | Jun 1997 | A |
5640970 | Arenas | Jun 1997 | A |
5643298 | Nordgren et al. | Jul 1997 | A |
5645529 | Fagan et al. | Jul 1997 | A |
5655548 | Nelson et al. | Aug 1997 | A |
5664580 | Erickson et al. | Sep 1997 | A |
5695111 | Nanis et al. | Dec 1997 | A |
5695506 | Pike et al. | Dec 1997 | A |
5720300 | Fagan | Feb 1998 | A |
5722424 | Engelson | Mar 1998 | A |
5728133 | Kontos et al. | Mar 1998 | A |
5741270 | Hansen et al. | Apr 1998 | A |
5741429 | Donadio et al. | Apr 1998 | A |
5769796 | Palermo et al. | Jun 1998 | A |
5779721 | Nash et al. | Jul 1998 | A |
5807241 | Heimberger et al. | Sep 1998 | A |
5824071 | Nelson et al. | Oct 1998 | A |
5830222 | Makower et al. | Nov 1998 | A |
5830224 | Cohn et al. | Nov 1998 | A |
5833631 | Nguyen | Nov 1998 | A |
5840046 | Deem | Nov 1998 | A |
5843050 | Jones et al. | Dec 1998 | A |
5871528 | Camps et al. | Feb 1999 | A |
5882329 | Patterson et al. | Mar 1999 | A |
5885227 | Finlayson | Mar 1999 | A |
5891055 | Sauter | Apr 1999 | A |
5910133 | Gould et al. | Jun 1999 | A |
5916194 | Jacobsen et al. | Jun 1999 | A |
5924998 | Cornelius et al. | Jul 1999 | A |
5935108 | Katoh et al. | Aug 1999 | A |
5944686 | Patterson et al. | Aug 1999 | A |
5947940 | Beisel et al. | Sep 1999 | A |
5951494 | Wang et al. | Sep 1999 | A |
5954713 | Newman et al. | Sep 1999 | A |
5957900 | Ouchi et al. | Sep 1999 | A |
5968064 | Selmon et al. | Oct 1999 | A |
5984878 | Engelson | Nov 1999 | A |
5989276 | Houser et al. | Nov 1999 | A |
5997517 | Whitbourne | Dec 1999 | A |
6010449 | Selmon et al. | Jan 2000 | A |
6013055 | Bampos et al. | Jan 2000 | A |
6015405 | Schwartz et al. | Jan 2000 | A |
6022343 | Johnson et al. | Feb 2000 | A |
6027460 | Shturman | Feb 2000 | A |
6036707 | Spaulding et al. | Mar 2000 | A |
6036717 | Mers Kelly et al. | Mar 2000 | A |
6042876 | Deem | Mar 2000 | A |
6059750 | Fogarty et al. | May 2000 | A |
6068638 | Makower et al. | May 2000 | A |
6071281 | Burnside et al. | Jun 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6081738 | Hinohara et al. | Jun 2000 | A |
6099542 | Cohn et al. | Aug 2000 | A |
6106485 | McMahon | Aug 2000 | A |
6117064 | Apple et al. | Sep 2000 | A |
6120516 | Selmon et al. | Sep 2000 | A |
6126649 | VanTassel et al. | Oct 2000 | A |
6139540 | Rost et al. | Oct 2000 | A |
6155264 | Ressemann et al. | Dec 2000 | A |
6157852 | Selmon et al. | Dec 2000 | A |
6159225 | Makower et al. | Dec 2000 | A |
6183432 | Milo | Feb 2001 | B1 |
6186972 | Nelson et al. | Feb 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6203559 | Davis | Mar 2001 | B1 |
6217527 | Selmon et al. | Apr 2001 | B1 |
6217549 | Selmon et al. | Apr 2001 | B1 |
6221049 | Selmon et al. | Apr 2001 | B1 |
6231546 | Milo et al. | May 2001 | B1 |
6231587 | Makower | May 2001 | B1 |
6235000 | Milo et al. | May 2001 | B1 |
6241667 | Vetter et al. | Jun 2001 | B1 |
6245030 | DuBois et al. | Jun 2001 | B1 |
6246914 | de la Rama et al. | Jun 2001 | B1 |
6254588 | Jones et al. | Jul 2001 | B1 |
6258052 | Milo | Jul 2001 | B1 |
6266550 | Selmon et al. | Jul 2001 | B1 |
6277133 | Kanesaka | Aug 2001 | B1 |
6283940 | Mulholland | Sep 2001 | B1 |
6283951 | Flaherty et al. | Sep 2001 | B1 |
6283983 | Makower et al. | Sep 2001 | B1 |
6287317 | Makower et al. | Sep 2001 | B1 |
6302875 | Makower et al. | Oct 2001 | B1 |
6330884 | Kim | Dec 2001 | B1 |
6337142 | Harder et al. | Jan 2002 | B2 |
6358244 | Newman et al. | Mar 2002 | B1 |
6375615 | Flaherty et al. | Apr 2002 | B1 |
6387119 | Wolf et al. | May 2002 | B2 |
6398798 | Selmon et al. | Jun 2002 | B2 |
6416523 | Lafontaine | Jul 2002 | B1 |
6428552 | Sparks | Aug 2002 | B1 |
6432127 | Kim et al. | Aug 2002 | B1 |
6447539 | Nelson et al. | Sep 2002 | B1 |
6475226 | Belef et al. | Nov 2002 | B1 |
6485458 | Takahashi | Nov 2002 | B1 |
6491660 | Guo et al. | Dec 2002 | B2 |
6491707 | Makower et al. | Dec 2002 | B2 |
6506178 | Schubart et al. | Jan 2003 | B1 |
6508824 | Flaherty et al. | Jan 2003 | B1 |
6508825 | Selmon et al. | Jan 2003 | B1 |
6511458 | Milo et al. | Jan 2003 | B2 |
6514217 | Selmon et al. | Feb 2003 | B1 |
6544230 | Flaherty et al. | Apr 2003 | B1 |
6561998 | Roth et al. | May 2003 | B1 |
6565583 | Deaton | May 2003 | B1 |
6569129 | Holmes, Jr. et al. | May 2003 | B1 |
6569143 | Alchas et al. | May 2003 | B2 |
6569145 | Shmulewitz et al. | May 2003 | B1 |
6569150 | Teague et al. | May 2003 | B2 |
6579311 | Makower | Jun 2003 | B1 |
6589164 | Flaherty | Jul 2003 | B1 |
6599304 | Selmon et al. | Jul 2003 | B1 |
6602241 | Makower et al. | Aug 2003 | B2 |
6613081 | Kim et al. | Sep 2003 | B2 |
6616675 | Evard et al. | Sep 2003 | B1 |
6623448 | Slater | Sep 2003 | B2 |
6638247 | Selmon et al. | Oct 2003 | B1 |
6638293 | Makower et al. | Oct 2003 | B1 |
6655386 | Makower et al. | Dec 2003 | B1 |
6656195 | Peters et al. | Dec 2003 | B2 |
6660024 | Flaherty et al. | Dec 2003 | B1 |
6669709 | Cohn et al. | Dec 2003 | B1 |
6685648 | Flaherty et al. | Feb 2004 | B2 |
6685716 | Flaherty et al. | Feb 2004 | B1 |
6694983 | Wolf et al. | Feb 2004 | B2 |
6709444 | Makower | Mar 2004 | B1 |
6719725 | Milo et al. | Apr 2004 | B2 |
6726677 | Flaherty et al. | Apr 2004 | B1 |
6746426 | Flaherty et al. | Jun 2004 | B1 |
6746462 | Selmon et al. | Jun 2004 | B1 |
6746464 | Makower | Jun 2004 | B1 |
6786884 | DeCant, Jr. et al. | Sep 2004 | B1 |
6800085 | Selmon et al. | Oct 2004 | B2 |
6824550 | Noriega et al. | Nov 2004 | B1 |
6830577 | Nash et al. | Dec 2004 | B2 |
6837868 | Fajnsztajn | Jan 2005 | B1 |
6860892 | Tanaka | Mar 2005 | B1 |
6863684 | Kim et al. | Mar 2005 | B2 |
6866676 | Kieturakis et al. | Mar 2005 | B2 |
6884225 | Kato et al. | Apr 2005 | B2 |
6905505 | Nash et al. | Jun 2005 | B2 |
6929009 | Makower et al. | Aug 2005 | B2 |
6936056 | Nash et al. | Aug 2005 | B2 |
6942641 | Seddon | Sep 2005 | B2 |
6949125 | Robertson | Sep 2005 | B2 |
6991617 | Hektner et al. | Jan 2006 | B2 |
7004173 | Sparks et al. | Feb 2006 | B2 |
7056325 | Makower et al. | Jun 2006 | B1 |
7059330 | Makower et al. | Jun 2006 | B1 |
7083588 | Shmulewitz et al. | Aug 2006 | B1 |
7094230 | Flaherty et al. | Aug 2006 | B2 |
7105031 | Letort | Sep 2006 | B2 |
7134438 | Makower et al. | Nov 2006 | B2 |
7137990 | Hebert et al. | Nov 2006 | B2 |
7159592 | Makower et al. | Jan 2007 | B1 |
7179270 | Makower | Feb 2007 | B2 |
7191015 | Lamson et al. | Mar 2007 | B2 |
7229421 | Jen et al. | Jun 2007 | B2 |
7316655 | Ganbotto et al. | Jan 2008 | B2 |
7377910 | Katoh et al. | May 2008 | B2 |
7465286 | Patterson et al. | Dec 2008 | B2 |
20010000041 | Selmon et al. | Mar 2001 | A1 |
20010056273 | C | Dec 2001 | A1 |
20020029052 | Evans et al. | Mar 2002 | A1 |
20020052637 | Houser et al. | May 2002 | A1 |
20020103459 | Sparks et al. | Aug 2002 | A1 |
20030028200 | Berg et al. | Feb 2003 | A1 |
20030040737 | Merril et al. | Feb 2003 | A1 |
20030109809 | Jen et al. | Jun 2003 | A1 |
20030120195 | Milo et al. | Jun 2003 | A1 |
20030167038 | Yozu et al. | Sep 2003 | A1 |
20030236542 | Makower | Dec 2003 | A1 |
20040015193 | Lamson et al. | Jan 2004 | A1 |
20040059280 | Makower et al. | Mar 2004 | A1 |
20040102719 | Keith et al. | May 2004 | A1 |
20040133225 | Makower | Jul 2004 | A1 |
20040158143 | Flaherty et al. | Aug 2004 | A1 |
20040167554 | Simpson et al. | Aug 2004 | A1 |
20040230156 | Schreck et al. | Nov 2004 | A1 |
20040249277 | Kato et al. | Dec 2004 | A1 |
20040249338 | DeCant, Jr. et al. | Dec 2004 | A1 |
20050038467 | Hebert et al. | Feb 2005 | A1 |
20050049574 | Petrick et al. | Mar 2005 | A1 |
20050096568 | Kato | May 2005 | A1 |
20050171478 | Selmon et al. | Aug 2005 | A1 |
20050177105 | Shalev | Aug 2005 | A1 |
20050216044 | Hong | Sep 2005 | A1 |
20050261663 | Patterson et al. | Nov 2005 | A1 |
20060009715 | Khairkhahan | Jan 2006 | A1 |
20060094930 | Sparks et al. | May 2006 | A1 |
20060135984 | Kramer et al. | Jun 2006 | A1 |
20060200047 | Galdonik | Sep 2006 | A1 |
20060229646 | Sparks | Oct 2006 | A1 |
20060271078 | Modesitt | Nov 2006 | A1 |
20060293612 | Jenson et al. | Dec 2006 | A1 |
20070083220 | Shamay | Apr 2007 | A1 |
20070088230 | Terashi et al. | Apr 2007 | A1 |
20070093779 | Kugler et al. | Apr 2007 | A1 |
20070093780 | Kugler et al. | Apr 2007 | A1 |
20070093781 | Kugler et al. | Apr 2007 | A1 |
20070093782 | Kugler et al. | Apr 2007 | A1 |
20070093783 | Kugler et al. | Apr 2007 | A1 |
20070191778 | Venbrux | Aug 2007 | A1 |
20070265596 | Jen et al. | Nov 2007 | A1 |
20080097247 | Eskuri | Apr 2008 | A1 |
20080103443 | Kabrick et al. | May 2008 | A1 |
20080228171 | Kugler et al. | Sep 2008 | A1 |
20080243065 | Rottenberg et al. | Oct 2008 | A1 |
20080243067 | Rottenberg et al. | Oct 2008 | A1 |
20090088685 | Kugler et al. | Apr 2009 | A1 |
20090124899 | Jacobs et al. | May 2009 | A1 |
20090198153 | Shriver | Aug 2009 | A1 |
20090209910 | Kugler et al. | Aug 2009 | A1 |
20090270890 | Robinson et al. | Oct 2009 | A1 |
20100063534 | Kugler et al. | Mar 2010 | A1 |
Number | Date | Country |
---|---|---|
2209637 | Jul 1996 | CA |
2251685 | Sep 1998 | CA |
820782 | Jan 2002 | EP |
868924 | Dec 2004 | EP |
08257136 | Oct 1996 | JP |
2007-089901 | Apr 2007 | JP |
9839041 | Sep 1998 | WO |
0178822 | Dec 2002 | WO |
2008063621 | Aug 2008 | WO |
2007033052 | Apr 2009 | WO |
2009054943 | Apr 2009 | WO |
2009100129 | Oct 2009 | WO |
2009134346 | Jan 2010 | WO |
2010019241 | Feb 2010 | WO |
2010044816 | Apr 2010 | WO |
Number | Date | Country | |
---|---|---|---|
20130110144 A1 | May 2013 | US |
Number | Date | Country | |
---|---|---|---|
61063756 | Feb 2008 | US | |
61104868 | Oct 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12461261 | Aug 2009 | US |
Child | 13719687 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12320792 | Feb 2009 | US |
Child | 12461261 | US |